Prevención de la infección por Streptococcus del grupo B en gestantes

• Martínez Sánchez, Lina María ; Restrepo Arango, Marcos ^[1] ; Sánchez Díaz, Emmanuel ^[1] ; Marín Cárdenas, Juan Sebastián ^[1] ; Gallego González, Daniel ^[1] ; Velez Pelaez, Maria Camila
  1. [1] Universidad Pontificia Bolivariana

     Universidad Pontificia Bolivariana

     Colombia

     
• Localización: MedUNAB, ISSN-e 2382-4603, ISSN 0123-7047, Vol. 20, Nº. 2, 2017 (Ejemplar dedicado a: Prevention of Falls, Education Medical, Leishmaniasis Cutaneous), págs. 182-189
• Idioma: español
• DOI: 10.29375/01237047.2308
• Títulos paralelos:
  • Prevention of Group B Streptococcal Infection in Pregnant Women
• Enlaces
  • Texto completo
• Resumen
  • español

    Introducción: La infección neonatal por Streptococcus del Grupo B en mujeres gestantes es un problema creciente a nivel mundial y tiene múltiples consecuencias para el recién nacido, su prevención impacta directamente la morbi-mortalidad neonatal.  Objetivo: Brindar al lector información relevante sobre la importancia clínica, nuevos métodos de tamizaje y formas de prevención de la infección por Streptococcus del Grupo B en gestantes, que será de utilidad para evitar complicaciones del binomio materno-fetal. Metodología: En esta revisión de la literatura, se estudiaron 53 artículos, abordando evidencia tanto en el ámbito local e internacional, utilizando las bases de datos PubMed, ScienceDirect y Google Scholar, dentro los criterios de búsqueda se tuvo en cuenta el año de publicación, incluyendo artículos que fueron publicados a partir del año 2011. Resultados: La comunidad internacional ha desarrollado guías y planes de prevención; en la actualidad, para una profilaxis y prevención adecuada se proponen diversos métodos, partiendo del tamizaje para las maternas, uso de antibióticos durante el embarazo y parto, además del desarrollo de vacunas maternas para prevenir infecciones. Conclusiones: La colonización por Streptococcus del Grupo B en gestantes y el riesgo que conlleva para el recién nacido y su madre, exige una constante actualización en técnicas de tamizaje, prevención y manejo. Numerosos avances en estos campos vienen llevándose a cabo en los últimos años y su fortalecimiento y desarrollo será clave para impactar positivamente la morbi-mortalidad materno-fetal. [Martínez-Sánchez LM, Restrepo-Arango M, Sánchez-Díaz E, Marín-Cárdenas JS, Gallego-González D, Vélez-Peláez MC.  Prevención de la infección por Streptococcus del grupo B en gestantes. MedUNAB 2017; 20(2): 182-189].

  • English

    Introduction: The neonatal infection by Group B Streptococcus in pregnant women is a growing problem worldwide and has multiple consequences for the newborn, so its prevention directly impacts neonatal morbimortality. Objective: To provide the reader with relevant information about the clinical importance, new screening methods and ways to prevent Group B Streptococcus infection in pregnant women which will be useful to avoid complications in the pairing of maternal-fetal. Methodology: In this review of literature, 53 articles were studied addressing local and international evidence by using PubMed, ScienceDirect and Google Scholar databases; within the search criteria the year of publication was taken into account to do so, thus articles published from 2011 were included. Results: The international community has developed guidelines and prevention plans for this infection. Currently, for an adequate prophylaxis and prevention, various methods are proposed such as the screening for expectant mothers, the use of antibiotics during pregnancy and childbirth, and the development of maternal immunization to prevent infections as well. Conclusions: The colonization by Group B Streptococcus in pregnant women and the risk that this entails to the newborn and his/her mother requires constant updating in techniques for screening, prevention and management of it. Numerous advances in these fields of study have been carried out in recent years, and this strengthening and its development will be the key to impact, in a positive way, the maternal-fetal morbimortality. [Martínez-Sánchez LM, Restrepo-Arango M, Sánchez-Díaz E, Marín-Cárdenas JS, Gallego-González D, Vélez-Peláez MC. Prevention of Group B Streptococcal Infection in Pregnant Women. MedUNAB 2017; 20(2): 182-189].

• Referencias bibliográficas
  • Referencias bibliográficas 1. Cape A, Tuomala RE, Taylor C, Puopolo KM. Peripartum bacteremia in the era of group B streptococcus prophylaxis....
  • Chan GJ, Lee AC, Baqui AH, Tan J, Black RE. Risk of early-onset neonatal infection with maternal infection or colonization: a global systematic...
  • Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev. 2013; 3:CD007467....
  • Faro J. More rapid testing group B streptococcus detection. MLO Med Lab Obs. 2013; 45(6):15. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23875438
  • Baker CJ. The spectrum of perinatal group B streptococcal disease. Vaccine. 2013; 31 Suppl 4:D3-6. Disponible en: http://goo.gl/ZYboLp .
  • Kruk CR, Feuerschuette OH, da Silveira SK, Cordazo M, Trapani Júnior A. Epidemiologic profile of Streptococcus agalactiae colonization in...
  • Page-Ramsey SM, Johnstone SK, Kim D, Ramsey PS. Prevalence of group B Streptococcus colonization in subsequent pregnancies of group B Streptococcus-colonized...
  • Berardi A, Rossi C, Creti R, China M, Gherardi G, Venturelli C, et al. Group B streptococcal colonization in 160 mother-baby pairs: a prospective...
  • Oh W. Early onset neonatal group B streptococcal sepsis. Am J Perinatol. 2013; 30(2):143-7. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23322392...
  • Brzychczy-Wloch M, Wojkowska-Mach J, Helwich E, Heczko PB. Incidence of maternal SGB colonization and neonatal SGB disease among very low...
  • Berardi A, Rossi C, Lugli L, Creti R, Bacchi ML, Lanari M, et al. SGB Prevention Working Group, Emilia-Romagna. Group B streptococcus late-onset...
  • Park JS, Cho DH, Yang JH, Kim MY, Shin SM, Kim EC, et al. Usefulness of a rapid real-time PCR assay in prenatal screening for group B streptococcus...
  • Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR. The accuracy of late antenatal screening cultures in predicting genital group B...
  • Verani J, McGee L, Schrag S. Prevention of perinatal group B streptococcal disease, 2010. MMWR Recomm Rep. 2010; 59:1-36.
  • Sheehy A, Davis D, Homer CS. Assisting women to make informed choices about screening for Group B Streptococcus in pregnancy: a critical review...
  • Guerrero C, Martinez J, Menasalvas A, Blazquez R, Rodriguez T, Segovia M. Use of direct latex agglutination testing of selective broth in...
  • Bourgeois-Nicolaos N, Cordier AG, Guillet-Caruba C, Casanova F, Benachi A, Doucet-Populaire F. Evaluation of the Cepheid Xpert SGB assay for...
  • Faro JP, Bishop K, Riddle G, Ramirez MM, Katz AR, Turrentine MA, et al. Accuracy of an accelerated, culture-based assay for detection of group...
  • Poncelet-Jasserand E, Forges F, Varlet MN, Chauleur C, Seffert P, Siani C, et al. Reduction of the use of antimicrobial drugs following the...
  • Berg BR, Houseman JL, Garrasi MA, Young CL, Newton DW. Culture-based method with performance comparable to that of PCR-based methods for detection...
  • Burns G, Plumb J. GBS public awareness, advocacy, and prevention--what's working, what's not and why we need a maternal GBS vaccine....
  • Horváth B, Grasselly M, Bödecs T, Boncz I, Bódis J. Screening pregnant women for group B streptococcus infection between 30 and 32weeks of...
  • Kimura K, Matsubara K, Yamamoto G, Shibayama K, Arakawa Y. Active screening of group B streptococci with reduced penicillin susceptibility...
  • Capanna F, Emonet SP, Cherkaoui A, Irion O, Schrenzel J, Martinez de Tejada B. Antibiotic resistance patterns among group B Streptococcus...
  • Duque CM, Gómez B, Sánchez DM , Uribe OL. Perfil de sensibilidad de S. agalactiae obtenido a partir de muestras de introito vaginal y región...
  • Crespo-Ortiz Mdel P, Castañeda-Ramirez CR, Recalde-Bolaños M, Vélez-Londoño JD. Emerging trends in invasive and noninvasive isolates of Streptococcus...
  • Megged O, Assous M, Weinberg G, Schlesinger Y. Inducible clindamycin resistance in β-hemolytic streptococci and Streptococcus pneumoniae....
  • Paccione KA, Wiesenfeld HC. Guideline adherence for intrapartum group B streptococci prophylaxis in penicillin-allergic patients. Infect Dis...
  • Simons FE, Schatz M. Anaphylaxis during pregnancy. J Allergy Clin Immunol. 2013; 130(3):597-606. Disponible en: http://goo.gl/ppJ1Uc .
  • Faro J, Katz A, Ramirez M, Turrentine M, Bishop K, Riddle G, et al. Rapid test for growth and determination of antibiotic sensitivity of Group...
  • Fairlie T, Zell ER, Schrag S. Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease....
  • Turrentine MA, Greisinger AJ, Brown KS, Wehmanen OA, Mouzoon ME. Duration of intrapartum antibiotics for group B streptococcus on the diagnosis...
  • Schrag SJ, Verani JR. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the...
  • Centers for Disease Control and Prevention. Prevention of Perinatal Group B Streptococcal Disease Revised Guidelines from CDC, 2010. Disponible...
  • Bromiker R, Ernest N, Meir MB, Kaplan M, Hammerman C, Schimmel MS, et al . Correlation of bacterial type and antibiotic sensitivity with maternal...
  • Natale F, Brunelli R, Bizzarri B, Castronovo A, De Curtis M. Cervical insufficiency: a new issue for guidelines on prevention of perinatal...
  • Swamy GK, Garcia-Putnam R. Vaccine-preventable diseases in pregnancy. Am J Perinatol. 2013; 30(2):89-97. Disponible en: http://goo.gl/KRG4ed...
  • Esposito S, Bosis S, Morlacchi L, Baggi E, Sabatini C, Principi N. Can infants be protected by means of maternal vaccination? Clin Microbiol...
  • Lindsey B, Kampmann B, Jones C. Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants. Curr Opin...
  • Melin P, Efstratiou A. Group B streptococcal epidemiology and vaccine needs in developed countries. Vaccine. 2013; 28;31 Suppl 4:D31-42. Disponible...
  • Kasper DL, Paoletti LC, Wessels MR, Guttormsen HK, Carey VJ, Jennings HJ, Baker CJ. Immune response to type III group B streptococcal polysaccharide-tetanus...
  • Madhi SA, Dangor Z, Heath PT, Schrag S, Izu A, Sobanjo-Ter Meulen A, et al . Considerations for a phase-III trial to evaluate a group B Streptococcus...
  • Munoz FM, Ferrieri P. Group B Streptococcus vaccination in pregnancy: moving toward a global maternal immunization program. Vaccine. 2013;...
  • Souza VC, Kegele FC, Souza SR, Neves FP, de Paula GR, Barros RR. Antimicrobial susceptibility and genetic diversity of Streptococcus agalactiae...
  • Bellais S, Six A, Fouet A, Longo M, Dmytruk N, Glaser P, Trieu-Cuot P, Poyart C. Capsular switching in group B Streptococcus CC17 hypervirulent...
  • Brzychczy-Wloch M, Gorska S, Brzozowska E, Gamian A, Heczko PB, Bulanda M. Identification of high immunoreactive proteins from Streptococcus...
  • Chen VL, Avci FY, Kasper DL. A maternal vaccine against group B Streptococcus: past, present, and future. Vaccine. 2013; 31 Suppl 4:D13-9....
  • Edwards MS, Gonik B. Preventing the broad spectrum of perinatal morbidity and mortality through group B streptococcal vaccination. Vaccine....
  • Edwards MS, Lane HJ, Hillier SL, Rench MA, Baker CJ. Persistence of functional antibodies to group B streptococcal capsular polysaccharides...
  • Le Doare K, Heath PT. An overview of global GBS epidemiology. Vaccine. 2013; 31 Suppl 4:D7-12. Disponible en: http://goo.gl/tnjV00 .
  • Koumans EH, Rosen J, van Dyke MK, Zell E, Phares CR, Taylor A,et al . Prevention of mother-to-child transmission of infections during pregnancy:...
  • Johri AK, Lata H, Yadav P, Dua M, Yang Y, Xu X, et al. Epidemiology of Group B Streptococcus in developing countries. Vaccine. 2013; 31 Suppl...
  • Dagnew AF, Cunnington MC, Dube Q, Edwards MS, French N, Heyderman RS,et al. Variation in reported neonatal group B streptococcal disease incidence...